Covid-19: Pfizer and BioNTech submit vaccine for US authorisation
- 20 November 2020
- news
- news
- Published by BMJ
- Vol. 371, m4552
- https://doi.org/10.1136/bmj.m4552
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialThe Lancet, 2020
- Covid-19: Moderna vaccine is nearly 95% effective, trial involving high risk and elderly people showsPublished by BMJ ,2020
- Covid-19: Vaccine candidate may be more than 90% effective, interim results indicatePublished by BMJ ,2020